Media News

SHANGHAI, March 4, 2022 /PRNewswire/ -- On February 23, 2022, 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company in China, signed a strategic cooperation agreement on direct supply with Xi'an Beilin Pharmaceutical Co., Ltd. ("Beilin Pharmaceutical"). The cooperation agreement will allow the two sides to fully leverage their respective advantages, explore the...

HONG KONG, March 4, 2022 /PRNewswire/ -- Hong Kong Life is committed to providing appropriate and comprehensive protection plans for our customers and helping them embrace a healthy life. In view of the ongoing COVID-19 epidemic and the increase in confirmed cases, Hong Kong Life specially provides customers with "Health Amulet" Free Benefit. From 1 March to 31 March...

SEOUL, South Korea, March 4, 2022 /PRNewswire/ -- Genome and Company (KOSDAQ: 314130, CEO∙CTO: Jisoo Pae∙Hansoo Park), a leading global microbiome anti-cancer drug development company, announced it has entered into a first Clinical Trial Collaboration and Supply Agreement (CTCSA) with MSD (a tradename of Merck & Co., Inc., Kenilworth, N.J., USA). Upon...

GENEVA, March 4, 2022 /PRNewswire/ -- To mark International HPV Awareness Day March 4th 2022, the International Papillomavirus Society (IPVS) has warmly welcomed two major advances in the elimination of cervical and anal cancers. Vaccinating boys and girls can help us eliminate HPV and related cancers within one generation HPV...

NANJING, China, March 4, 2022 /PRNewswire/ -- InxMed Co., Ltd, a clinical-stage biotechnology company dedicated to developing innovative therapies targeting stroma microenvironment and drug resistance for hard-to-treat solid tumors, today announced that it had completed $50 million in Series B Financing. The Series B was led by CS Capital, with the participation of AIHC Fund, Growth Fund and...

SHANGHAI, March 3, 2022 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T cell therapies for the treatment of hematologic malignancies and solid tumors, today announced that the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) of China has approved the initiation...

SHANGHAI and GAITHERSBURG, Md., March 3, 2022 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel biologics, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for TJ-CD4B, a novel Claudin 18.2 x 4-1BB bispecific antibody, for the treatment of gastric cancer...

GOTHENBURG, Sweden, March 3, 2022 /PRNewswire/ -- Emollivet, a subsidiary of Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI), is now launching Emollivet COMBI: an antiseptic emollient spray for horses with pastern dermatitis. The product is released for the Swedish market and is available for purchase from 3rd March via Emollivet's e-commerce website www.emollivet.se  Pastern dermatitis is one of...

HONG KONG, March 3, 2022 /PRNewswire/ -- From personalized vaccines to lab-grown organs and AI-powered medical devices, the future of medicine is happening right now in labs across the world. This month on CNN's 'Vital Signs', Chief Medical Correspondent Dr. Sanjay Gupta speaks to the doctors and scientists working on ground-breaking technologies that could advance the world of medicine.  ...

GUANGZHOU, China, March 3, 2022 /PRNewswire/ -- Infinitus recently launched its first healthy drinks concept store at Guangzhou Infinitus Plaza in Guangzhou. The store provides shoppers a fast, convenient way to buy Infinitus' health products and serves as a new outlet that connects with and serves consumers. Infinitus' first healthy drinks concept store connects with young consumers The...